References African Development Bank. (2016). African Development Bank Accelerates Pace with ‘High 5’ Priorities. Abidjan: African Development Bank Group Aikins, A. D. G., Boynton, P., & Atanga, L. L. (2010). Developing effective chronic disease interventions in Africa: insights from Ghana and Cameroon. Globalization and health, 6(1), 1-15. Anderson, T. (2010). Tide turns for drug manufacturing in Africa. The Lancet, 375(9726), 1597-1598. Available at: here Asoko Insight (2019) ‘Kenya’s leading pharmaceutical companies. Webpage (https:// asokoinsight.com/content/quick-ins i g h t s / ke nya - l e a d i n g - p h a r m a ce u t i cal-companies). AUC-UNIDO (2012). Pharmaceutical manufacturing plan for Africa. Available here Banga, K., Keane, J., Mendez-Parra, M., Pettinotti, L., & Sommer, L. (2020). Africa trade and Covid‑19: The supply chain dimension. Working paper 586. African Trade Policy Center. Available here Broccoli, M. C., Pigoga, J. L., Nyirenda, M., Wallis, L. A., & Hynes, E. C. (2018). Essential medicines for emergency care in Africa. African Journal of Emergency Medicine, 8(3), 110-117. Cartwright, R and Baric, A (2018). The rise of counterfeit pharmaceuticals in Africa. Available here Chaudhuri, S., Mackintosh, M., & Mujinja, P. G. (2010). Indian generics producers, access to essential medicines and local production in Africa: an argument with reference to Tanzania. The European Journal of Development Research, 22(4), 451-468. Available here Clinton Health Access Initiative (2016). Accelerating Local Manufacture of cGMP Quality Assured Pharmaceutical Products in East Africa, Final Report. EAC (2012) East African Community Regional Pharmaceutical Manufacturing Plan of Action (2012 - 2016), East African Community (EAC) Secretariat, Arusha, United Republic of Tanzania. Available here
22
EAC (2018) 2nd EAC Regional Pharmaceutical Manufacturing Plan of Action 2017–2027, East African Community (EAC) Secretariat, Arusha, United Republic of Tanzania. Available here Ekeigwe, A. A. (2019). Drug manufacturing and access to medicines: The West African story. A literature review of challenges and proposed remediation. AAPS Open, 5(1), 3. Available here EQUINET (2013). Overcoming barriers to medicines production through South-South co-operation in Africa. Policy brief No. 34. Available here GBD Results Tool | GHDx. Ghdx.healthdata.org. (2019). Retrieved 26 November 2020, from http://ghdx.healthdata.org/gbd-results-tool. Grasswitz, T. R., Leyland, T. J., Musiime, J. T., Owens, S. J., & Sones, K. R. (2004). The veterinary pharmaceutical industry in Africa: a study of Kenya, Uganda and South Africa. African Union/Inter-African Bureau for Animal Resources (AU/IBAR), Nairobi, Kenya. Holt, T., Lahrichi, M., & Santos da Silva, J. (2015). Africa: A continent of opportunity for pharma and patients. McKinsey & Company. Available here Ismail, F. (2018). A “Developmental Regionalism” approach to the AfCFTA. Working Paper. Pretoria: Trade and Industrial Policy Strategies (TIPS). Available here Kaplan, W., & Laing, R. (2005). Local production of pharmaceuticals: Industrial policy and access to medicines, An overview of key concepts, Issues and opportunities for future research. Available here Kardas-Nelson, M. (2015). Can (and should) Africa make its own medicines? Bmj, 350. Lopes, C. and Te Velde, W. (2021). Structural Transformation, Economic Development and Industrialization in Post-Covid-19 Africa, Institute for New Economic Thinking (INET), 14 Jan 2021. https://protect-za. mimecast.com/s/tGjGC98A5gU4ko4DFZkiM, https://www.ineteconomics.org/ perspectives/blog/structural-transformation-economic-development-and-in-
